We reanalyzed the data in Samogy-Costa paper[2] and found that of 34 patients with 22q13.3 deletion syndrome, 15 (44.1%, 15/34) carry the deletion of CELSR1, while only 4 of them (4/15, 26.7%) reported lymphedema. The gene discussed is CELSR1; the disease is lymphedema.